British Journal of Haematology · 1994 · 94 citations · 23 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyNeuropharmacologyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyDrug ToxicityHematopoietic ToxicitySchizophrenia PharmacotherapyAntipsychotic SafetyAntipsychotic ToxicologyClozapine PharmacologyMechanisms Of Toxic ActionOlanzapine PharmacologyPsychotropic Medication Toxicity
Clozapine, a novel antipsychotic drug that is particularly effective in treatment-resistant schizophrenia, causes severe agranulocytosis of unknown aetiology in approximately 0.8% of U.S. patients. We evaluated potential toxic mechanisms of drug-induced agranulocytosis. Clozapine, the two major metabolites N-desmethylclozapine and N-oxide clozapine, and five other clozapine derivatives were screened for toxicity to normal haemopoietic precursors. For all compounds except N-des-methylclozapine, toxicity to CFU-GM, BFU-E and CFU-GEMM occurred at concentrations at least 10 times the normal serum levels reported in unaffected patients. In contrast, the LD50 for N-desmethylclozapine was 2.5 micrograms/ml for CFU-GM, 3.2 micrograms/ml for BFU-E, and 2.4 micrograms/ml for CFU-GEMM, only 3-6 times the normal serum concentration. Bone marrow from patients with acute clozapine-induced agranulocytosis was not more sensitive to clozapine or N-desmethylclozapine than bone marrow from normal donors. These studies suggest that N-desmethylclozapine, the major metabolite of clozapine, is itself toxic or is further metabolized to an unstable compound which is toxic to haemopoietic precursors of both myeloid and erythroid lineages.
23
Clozapine for the Treatment-Resistant Schizophrenic
John M. Kane · Archives of General Psychiatry · 1988 · 4.1K citations
Medicine, Pharmacology, Psychiatry +16
A prospective study of clozapine in treatment-resistant schizophrenic patients
Herbert Y. Meltzer, Bahar Bastani, K. Young Kwon et al. · Psychopharmacology · 1989 · 270 citations
Agranulocytosis during treatment with clozapine
J. Id�np��n-Heikkil�, Eeva Alhava, M. Olkinuora et al. · European Journal of Clinical Pharmacology · 1977 · 235 citations
Clozapine: guidelines for clinical management.
Jeffrey A. Lieberman, John M. Kane, Celeste A. Johns · PubMed · 1989 · 226 citations
Medicine, Pharmacology, Psychiatry +16